Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TARS | Tarsus Pharmaceuticals, Inc.

IndexRUT P/E- EPS (ttm)-3.40 Insider Own5.50% Shs Outstand32.62M Perf Week5.02%
Market Cap505.28M Forward P/E- EPS next Y-4.95 Insider Trans-10.78% Shs Float28.42M Perf Month-2.31%
Income-91.00M PEG- EPS next Q-1.36 Inst Own77.10% Short Float / Ratio15.86% / 10.08 Perf Quarter-7.12%
Sales12.50M P/S40.42 EPS this Y-274.90% Inst Trans2.29% Short Interest4.51M Perf Half Y39.62%
Book/sh5.51 P/B3.08 EPS next Y-3.30% ROA-42.10% Target Price46.00 Perf Year4.44%
Cash/sh5.98 P/C2.83 EPS next 5Y- ROE-50.80% 52W Range11.33 - 25.25 Perf YTD15.62%
Dividend- P/FCF- EPS past 5Y- ROI-29.50% 52W High-32.87% Beta0.76
Dividend %- Quick Ratio12.40 Sales past 5Y- Gross Margin96.80% 52W Low49.60% ATR0.92
Employees87 Current Ratio12.40 Sales Q/Q- Oper. Margin- RSI (14)51.22 Volatility5.74% 4.89%
OptionableYes Debt/Eq0.17 EPS Q/Q-396.50% Profit Margin- Rel Volume0.83 Prev Close16.89
ShortableYes LT Debt/Eq0.17 EarningsAug 10 AMC Payout- Avg Volume447.22K Price16.95
Recom1.40 SMA202.14% SMA50-5.11% SMA2006.13% Volume369,777 Change0.36%
Date Action Analyst Rating Change Price Target Change
Jul-18-23Initiated William Blair Outperform $44
May-18-23Initiated Guggenheim Buy
Aug-01-22Initiated Barclays Overweight $40
Dec-21-21Initiated H.C. Wainwright Buy $40
Nov-23-21Initiated Oppenheimer Outperform $55
Nov-10-20Initiated Raymond James Strong Buy $39
Nov-10-20Initiated Ladenburg Thalmann Buy $42
Nov-10-20Initiated Jefferies Buy $35
Nov-10-20Initiated BofA Securities Buy $33
Sep-06-23 08:00AM
Aug-30-23 04:30PM
Aug-28-23 10:22AM
Aug-24-23 09:00AM
Aug-10-23 04:05PM
02:14PM Loading…
Aug-03-23 02:14PM
Aug-01-23 10:30PM
Jul-31-23 04:29PM
Jul-25-23 07:00AM
Jul-20-23 02:04PM
Jul-19-23 08:34PM
10:13AM
Jun-12-23 08:30AM
Jun-05-23 08:30AM
May-09-23 04:05PM
08:30AM Loading…
May-08-23 08:30AM
May-05-23 08:22AM
May-03-23 04:30PM
Apr-24-23 08:30AM
Apr-18-23 06:04AM
Apr-06-23 03:52PM
Mar-17-23 06:28AM
Mar-13-23 04:05PM
Mar-09-23 10:00AM
Mar-02-23 04:30PM
Feb-24-23 11:44AM
Jan-24-23 04:33AM
Dec-16-22 07:00AM
Dec-15-22 12:45PM
08:30AM
06:55AM Loading…
Dec-08-22 06:55AM
Nov-11-22 06:03AM
Nov-09-22 08:45AM
07:00AM
Oct-25-22 08:30AM
Oct-17-22 09:26AM
Oct-11-22 08:30AM
Oct-06-22 08:30AM
Sep-29-22 08:30AM
Sep-27-22 12:00PM
Sep-17-22 10:23AM
Sep-07-22 07:00AM
Aug-11-22 05:25PM
04:05PM
Aug-05-22 08:30AM
Jul-25-22 08:00AM
Jun-29-22 06:51AM
May-27-22 09:00AM
May-14-22 08:19AM
May-11-22 06:30AM
May-10-22 06:55PM
04:05PM
May-09-22 01:49PM
May-06-22 09:00AM
May-05-22 08:30AM
May-03-22 03:00PM
06:58AM
May-02-22 07:01AM
07:00AM
Apr-29-22 09:23PM
Apr-26-22 08:30AM
Apr-21-22 03:05AM
Mar-14-22 04:05PM
Mar-09-22 05:00PM
Feb-03-22 09:00AM
Feb-02-22 04:30PM
07:00AM
Jan-04-22 09:00AM
Nov-23-21 04:30PM
Nov-10-21 04:30PM
Nov-09-21 04:05PM
Nov-05-21 12:04PM
Nov-04-21 11:28AM
09:45AM
Nov-02-21 05:00PM
Oct-19-21 02:38PM
Oct-11-21 07:43PM
Aug-13-21 07:07AM
Aug-12-21 09:00AM
Aug-07-21 04:20AM
Aug-04-21 05:30PM
Jul-24-21 06:00PM
Jul-20-21 08:37AM
Jul-07-21 04:05PM
Jun-26-21 07:34AM
Jun-22-21 06:00AM
Jun-21-21 12:52PM
07:33AM
06:00AM
Jun-18-21 04:05PM
Jun-16-21 04:05PM
May-24-21 04:05PM
May-11-21 04:05PM
May-04-21 04:05PM
May-03-21 04:08PM
Apr-27-21 04:05PM
Apr-20-21 09:09AM
Mar-31-21 04:05PM
Mar-30-21 07:14AM
Mar-29-21 04:05PM
Tarsus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Azamian Bobak R.President/CEO and Board ChairSep 20Sale17.218,000137,680894,106Sep 22 05:30 PM
Azamian Bobak R.President/CEO and Board ChairAug 23Sale17.238,000137,840902,106Aug 25 05:12 PM
Lin Elizabeth YeuDirectorAug 15Buy16.809,506159,70115,866Aug 17 06:02 PM
Azamian Bobak R.President/CEO and Board ChairJul 19Sale20.01103,9002,078,984910,106Jul 21 05:42 PM
Mottiwala AzizChief Commercial OfficerJul 19Sale20.052,40048,12045,806Jul 21 05:46 PM
Azamian Bobak R.President/CEO and Board ChairJul 12Sale17.359,000156,1501,014,006Jul 14 04:40 PM
Azamian Bobak R.President/CEO and Board ChairJun 21Sale18.638,000149,0401,023,006Jun 23 04:29 PM
Azamian Bobak R.President/CEO and Board ChairJun 14Sale18.589,000167,2201,031,006Jun 16 04:48 PM
Azamian Bobak R.President/CEO and Board ChairJun 08Sale20.013,10062,0311,040,006Jun 12 05:40 PM
Mottiwala AzizChief Commercial OfficerJun 08Sale20.001002,00048,086Jun 12 05:25 PM
Mottiwala AzizChief Commercial OfficerJun 07Sale19.342,50048,35048,186Jun 08 07:16 PM
Mottiwala AzizChief Commercial OfficerJun 06Sale18.612,14339,88150,686Jun 08 07:16 PM
Azamian Bobak R.President/CEO and Board ChairMay 17Sale15.908,000127,2001,043,106May 19 07:08 PM
Azamian Bobak R.President/CEO and Board ChairMay 10Sale16.809,000151,2001,051,106May 12 05:08 PM
Azamian Bobak R.President/CEO and Board ChairMay 01Sale15.105,84188,1991,060,106May 02 07:06 PM
Azamian Bobak R.President/CEO and Board ChairApr 28Sale15.134,27864,7261,065,947May 02 07:06 PM
Azamian Bobak R.President/CEO and Board ChairApr 21Sale15.032,31134,7341,070,225Apr 25 05:22 PM
Greenstein Leonard M.Chief Financial OfficerApr 20Sale14.025,00070,10026,785Apr 21 05:53 PM
Azamian Bobak R.President/CEO and Board ChairApr 19Sale13.608,000108,8001,072,536Apr 21 05:49 PM
Azamian Bobak R.President/CEO and Board ChairMar 23Sale12.157378,9558,597Mar 23 07:50 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 23Sale12.154655,6506,107Mar 23 08:02 PM
Neervannan SeshadriChief Operating OfficerMar 23Sale12.153904,73854,696Mar 23 07:56 PM
Mottiwala AzizChief Commercial OfficerMar 23Sale12.153724,52052,829Mar 23 07:46 PM
Wahl BryanGeneral CounselMar 23Sale12.153714,50816,402Mar 23 07:52 PM
Greenstein Leonard M.Chief Financial OfficerMar 23Sale12.153464,20431,785Mar 23 08:04 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 23Sale12.153454,19211,219Mar 23 07:48 PM
Azamian Bobak R.President/CEO and Board ChairMar 22Sale12.647098,9629,334Mar 23 07:50 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 22Sale12.645296,6876,572Mar 23 08:02 PM
Neervannan SeshadriChief Operating OfficerMar 22Sale12.643794,79155,086Mar 23 07:56 PM
Wahl BryanGeneral CounselMar 22Sale12.643574,51216,773Mar 23 07:52 PM
Mottiwala AzizChief Commercial OfficerMar 22Sale12.643574,51253,201Mar 23 07:46 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 22Sale12.643334,20911,564Mar 23 07:48 PM
Greenstein Leonard M.Chief Financial OfficerMar 22Sale12.643324,19632,131Mar 23 08:04 PM
Azamian Bobak R.President/CEO and Board ChairMar 21Sale12.896798,75210,043Mar 23 07:50 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 21Sale12.895196,6907,101Mar 23 08:02 PM
Neervannan SeshadriChief Operating OfficerMar 21Sale12.893724,79555,465Mar 23 07:56 PM
Wahl BryanGeneral CounselMar 21Sale12.893504,51217,130Mar 23 07:52 PM
Mottiwala AzizChief Commercial OfficerMar 21Sale12.893494,49953,558Mar 23 07:46 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 21Sale12.893264,20211,897Mar 23 07:48 PM
Greenstein Leonard M.Chief Financial OfficerMar 21Sale12.893264,20232,463Mar 23 08:04 PM
Azamian Bobak R.President/CEO and Board ChairMar 20Sale12.617419,34410,722Mar 21 07:01 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 20Sale12.615306,6837,620Mar 21 07:10 PM
Neervannan SeshadriChief Operating OfficerMar 20Sale12.613804,79255,837Mar 21 07:12 PM
Mottiwala AzizChief Commercial OfficerMar 20Sale12.613584,51453,907Mar 21 07:08 PM
Wahl BryanGeneral CounselMar 20Sale12.613574,50217,480Mar 21 07:14 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 20Sale12.613334,19912,223Mar 21 07:17 PM
Greenstein Leonard M.Chief Financial OfficerMar 20Sale12.613334,19932,789Mar 21 07:03 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 20Sale12.611982,4973,191Mar 21 07:06 PM
Azamian Bobak R.President/CEO and Board ChairMar 17Sale13.2879510,55811,463Mar 21 07:01 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 17Sale13.285046,6938,150Mar 21 07:10 PM
Neervannan SeshadriChief Operating OfficerMar 17Sale13.283604,78156,217Mar 21 07:12 PM
Mottiwala AzizChief Commercial OfficerMar 17Sale13.283394,50254,265Mar 21 07:08 PM
Wahl BryanGeneral CounselMar 17Sale13.283394,50217,837Mar 21 07:14 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 17Sale13.283164,19612,556Mar 21 07:17 PM
Greenstein Leonard M.Chief Financial OfficerMar 17Sale13.283164,19633,122Mar 21 07:03 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 17Sale13.281882,4973,389Mar 21 07:06 PM
Greenstein Leonard M.Chief Financial OfficerMar 16Sale13.445,31371,40433,438Mar 17 06:04 PM
Azamian Bobak R.President/CEO and Board ChairMar 16Sale13.4379110,62312,258Mar 17 06:02 PM
Trevejo Jose M.Chief Medical OfficerMar 16Sale13.434996,7028,654Mar 17 06:18 PM
Neervannan SeshadriChief Operating OfficerMar 16Sale13.433574,79556,577Mar 17 06:15 PM
Wahl BryanGeneral CounselMar 16Sale13.433374,52618,176Mar 17 06:21 PM
Mottiwala AzizChief Commercial OfficerMar 16Sale13.433364,51254,604Mar 17 06:17 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 16Sale13.433134,20412,872Mar 17 06:20 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 16Sale13.431872,5113,577Mar 17 06:22 PM
Azamian Bobak R.President/CEO and Board ChairMar 15Sale13.798,000110,3201,080,536Mar 17 06:02 PM
Azamian Bobak R.President/CEO and Board ChairMar 09Sale15.0171710,7621,088,536Mar 10 05:13 PM
Azamian Bobak R.President/CEO and Board ChairMar 08Sale15.024,85372,8921,089,253Mar 10 05:13 PM
Greenstein Leonard M.Chief Financial OfficerFeb 16Sale15.125,00075,60034,289Feb 17 04:58 PM
Azamian Bobak R.President/CEO and Board ChairFeb 15Sale15.288,000122,2401,094,106Feb 17 04:54 PM
Azamian Bobak R.President/CEO and Board ChairFeb 08Sale15.149,000136,2601,102,106Feb 10 04:54 PM
Azamian Bobak R.President/CEO and Board ChairJan 23Sale15.454,85675,0251,111,106Jan 25 05:49 PM
Azamian Bobak R.President/CEO and Board ChairJan 20Sale15.002403,6001,116,373Jan 20 06:41 PM
Greenstein Leonard M.Chief Financial OfficerJan 19Sale14.565,00072,80039,289Jan 20 06:44 PM
Azamian Bobak R.President/CEO and Board ChairJan 18Sale14.568,000116,4801,116,613Jan 20 06:41 PM
Azamian Bobak R.President/CEO and Board ChairJan 11Sale15.113,90458,9891,124,613Jan 13 06:47 PM
Azamian Bobak R.President/CEO and Board ChairJan 10Sale15.1790513,7291,128,517Jan 11 08:26 PM
Azamian Bobak R.President/CEO and Board ChairJan 09Sale15.1572911,0441,129,422Jan 11 08:26 PM
Azamian Bobak R.President/CEO and Board ChairJan 06Sale15.004116,1651,129,740Jan 24 06:13 PM
Azamian Bobak R.President/CEO and Board ChairDec 21Sale14.578,000116,5601,130,151Dec 22 06:02 PM
Azamian Bobak R.President/CEO and Board ChairDec 16Sale15.015358,0301,138,151Dec 20 06:35 PM
Greenstein Leonard M.Chief Financial OfficerDec 15Sale14.645,00073,20044,289Dec 16 04:55 PM
Azamian Bobak R.President/CEO and Board ChairDec 14Sale15.086,42096,8141,138,686Dec 16 04:51 PM
Whitfield Dianne C.Chief Human Resources OfficerDec 02Sale16.901,15419,5038,723Dec 06 05:52 PM
Wahl BryanGeneral CounselDec 02Sale16.901,15419,50313,723Dec 06 05:49 PM
Whitfield Dianne C.Chief Human Resources OfficerDec 01Sale16.751,16519,5149,877Dec 01 08:09 PM
Wahl BryanGeneral CounselDec 01Sale16.751,16419,49714,877Dec 01 07:58 PM
Wahl BryanGeneral CounselNov 30Sale16.501,18319,52016,041Dec 01 07:58 PM
Whitfield Dianne C.Chief Human Resources OfficerNov 30Sale16.501,18219,50311,042Dec 01 08:09 PM
Wahl BryanGeneral CounselNov 29Option Exercise0.0010,251017,224Dec 01 07:58 PM
Whitfield Dianne C.Chief Human Resources OfficerNov 29Option Exercise0.0010,251012,224Dec 01 08:09 PM
Greenstein Leonard M.Chief Financial OfficerNov 17Sale16.545,00082,70049,289Nov 18 04:12 PM
Azamian Bobak R.President and CEONov 16Sale16.868,000134,8521,145,106Nov 18 04:09 PM
Mottiwala AzizChief Commercial OfficerNov 15Sale17.726,857121,50649,729Nov 17 05:30 PM
Azamian Bobak R.President and CEONov 09Sale17.879,000160,8301,153,106Nov 14 04:25 PM
Greenstein Leonard M.Chief Financial OfficerOct 20Sale15.925,00079,58954,289Oct 28 04:24 PM
Azamian Bobak R.President and CEOOct 19Sale16.928,000135,3491,162,106Oct 21 04:23 PM
Azamian Bobak R.President and CEOOct 12Sale15.919,000143,1941,170,106Oct 14 04:32 PM